95 related articles for article (PubMed ID: 1409090)
1. Texture analysis of histological images of giant cell tumor of bone.
Kuwahara H; Shimazaki M; Morikita I; Chanoki Y; Sakurai M
Pathol Res Pract; 1992 Jun; 188(4-5):565-9. PubMed ID: 1409090
[TBL] [Abstract][Full Text] [Related]
2. Quantitative pathological study of aggressiveness of giant cell tumor of bone.
Sun DQ; Feng CH; Fang JQ; Biesterfeld S; Boecking A
Chin Med J (Engl); 1991 Apr; 104(4):281-7. PubMed ID: 2065544
[TBL] [Abstract][Full Text] [Related]
3. An approach to a computer analysis of histologic images of giant cell tumor of bone and osteosarcoma.
Chanoki Y; Shimazaki M; Mitsuhashi T; Kuwahara H; Kanno T; Ishida T; Shimazu A; Yamashita K
Osaka City Med J; 1984 Dec; 30(2):147-59. PubMed ID: 6598866
[No Abstract] [Full Text] [Related]
4. Thallium-201 Uptake of Giant Cell Tumor: One Step Toward the Differential Diagnosis to Atypically Presenting Osteosarcoma.
Keller S; Inai R; Sato S; Tada A; Adam G; Yamamura J; Kanazawa S
AJR Am J Roentgenol; 2017 Jan; 208(1):171-179. PubMed ID: 27726429
[TBL] [Abstract][Full Text] [Related]
5. Proliferation index and vascular density of giant cell tumors of bone: are they prognostic markers?
Sulh MA; Greco MA; Jiang T; Goswami SB; Present D; Steiner G
Cancer; 1996 May; 77(10):2044-51. PubMed ID: 8640668
[TBL] [Abstract][Full Text] [Related]
6. [Cytogenesis and histogenesis of malignant and semimalignant bone tumors].
Roessner A; Grundmann E
Veroff Pathol; 1984; 122():1-195. PubMed ID: 6091360
[TBL] [Abstract][Full Text] [Related]
7. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
[TBL] [Abstract][Full Text] [Related]
8. Malignant tumors primary in bone (osteosarcoma, chondrosarcoma, fibrosarcoma, malignant giant cell tumor).
Bonfiglio M
Proc Natl Cancer Conf; 1970; 6():721-30. PubMed ID: 5272232
[No Abstract] [Full Text] [Related]
9. Needle biopsy of primary malignant bone tumors.
Hajdu SI; Melamed MR
Surg Gynecol Obstet; 1971 Nov; 133(5):829-32. PubMed ID: 4939087
[No Abstract] [Full Text] [Related]
10. Malignant bone tumors of the lower extremity.
Buxbaum FD
J Foot Surg; 1976; 15(3):85-92. PubMed ID: 1071753
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of bone tumors in Mexico City: retrospective clinicopathologic study of 566 patients at a referral institution.
Baena-Ocampo Ldel C; Ramirez-Perez E; Linares-Gonzalez LM; Delgado-Chavez R
Ann Diagn Pathol; 2009 Feb; 13(1):16-21. PubMed ID: 19118777
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous malignant transformation of conventional giant cell tumor.
Grote HJ; Braun M; Kalinski T; Pomjanski N; Back W; Bleyl U; Böcking A; Roessner A
Skeletal Radiol; 2004 Mar; 33(3):169-75. PubMed ID: 14749901
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative pathologic consultation (IOC) for tumors of the bone.
Mirra JM; Brien EW; Luck JV
Chir Organi Mov; 1997; 82(1):7-31. PubMed ID: 9269110
[TBL] [Abstract][Full Text] [Related]
14. Matrix vesicles in bone tumors. Ultrastructural analysis and their significance in neoplastic bone formation.
Yoshida H; Miyazaki S; Yumoto T
Acta Pathol Jpn; 1991 Aug; 41(8):610-7. PubMed ID: 1661059
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of bone GLA protein in primary bone tumors.
Iwasaki R; Yamamuro T; Kotoura Y; Okumura H; Kasai R; Nakashima Y
Cancer; 1992 Aug; 70(3):619-24. PubMed ID: 1320449
[TBL] [Abstract][Full Text] [Related]
16. [Differential diagnosis of giant cell tumor of bone].
Salzer-Kuntschik M
Verh Dtsch Ges Pathol; 1998; 82():154-9. PubMed ID: 10095427
[TBL] [Abstract][Full Text] [Related]
17. New cytomorphologic methods in the diagnosis of bone tumors: possibilities and limitations.
Roessner A; Mellin W; Hiddemann W; Voss B; Vollmer E; Grundmann E
Semin Diagn Pathol; 1984 Aug; 1(3):199-214. PubMed ID: 6600111
[TBL] [Abstract][Full Text] [Related]
18. Expression of bone morphogenetic proteins in giant cell tumor of bone.
Kudo N; Ogose A; Ariizumi T; Kawashima H; Hotta T; Hatano H; Morita T; Nagata M; Siki Y; Kawai A; Hotta Y; Hoshino M; Endo N
Anticancer Res; 2009 Jun; 29(6):2219-25. PubMed ID: 19528484
[TBL] [Abstract][Full Text] [Related]
19. "Dedifferentiation" in bone and soft-tissue tumors. A histological indicator of tumor progression.
Meis JM
Pathol Annu; 1991; 26 Pt 1():37-62. PubMed ID: 2014144
[No Abstract] [Full Text] [Related]
20. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
el-Naggar AK; Hurr K; Tu ZN; Teague K; Raymond KA; Ayala AG; Murray J
Cytometry; 1995 Mar; 19(3):256-62. PubMed ID: 7736870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
